Acquired hemophilia A: emerging treatment options
M Janbain, CA Leissinger… - Journal of Blood …, 2015 - Taylor & Francis
Acquired hemophilia A is a rare autoimmune disorder caused by an autoantibody (inhibitor)
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
Acquired hemophilia A: emerging treatment options
M Janbain, CA Leissinger… - Journal of Blood …, 2015 - search.proquest.com
Acquired hemophilia A is a rare autoimmune disorder caused by an autoantibody (inhibitor)
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
[HTML][HTML] Acquired hemophilia A: emerging treatment options
M Janbain, CA Leissinger… - Journal of Blood …, 2015 - ncbi.nlm.nih.gov
Acquired hemophilia A is a rare autoimmune disorder caused by an autoantibody (inhibitor)
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
[PDF][PDF] Acquired hemophilia A: emerging treatment options
M Janbain - Journal of Blood Medicine, 2015 - pdfs.semanticscholar.org
Acquired hemophilia A is a rare autoimmune disorder caused by an autoantibody (inhibitor)
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
Acquired hemophilia A: emerging treatment options.
M Janbain, CA Leissinger… - Journal of Blood …, 2015 - europepmc.org
Acquired hemophilia A is a rare autoimmune disorder caused by an autoantibody (inhibitor)
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
Acquired hemophilia A: emerging treatment options
M Janbain, CA Leissinger, R Kruse-Jarres - Journal of Blood Medicine, 2015 - go.gale.com
Acquired hemophilia A is a rare autoimmune disorder caused by an autoantibody (inhibitor)
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
Acquired hemophilia A: emerging treatment options
M Janbain, CA Leissinger… - Journal of blood …, 2015 - pubmed.ncbi.nlm.nih.gov
Acquired hemophilia A is a rare autoimmune disorder caused by an autoantibody (inhibitor)
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
[PDF][PDF] Acquired hemophilia A: emerging treatment options
M Janbain - Journal of Blood Medicine, 2015 - researchgate.net
Acquired hemophilia A is a rare autoimmune disorder caused by an autoantibody (inhibitor)
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
Acquired hemophilia A: emerging treatment options
M Janbain, CA Leissinger… - Journal of Blood …, 2015 - dovepress.com
Acquired hemophilia A is a rare autoimmune disorder caused by an autoantibody (inhibitor)
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
to factor VIII (FVIII) that interferes with its coagulant function and predisposes to severe …
[引用][C] Acquired hemophilia A: emerging treatment options
M Janbain - J Blood Med, 2015 - cir.nii.ac.jp
Acquired hemophilia A: emerging treatment options | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …